In vitro secreted aspartyl proteinase activity of Candida albicans isolated from oral diseases and healthy oral cavities

Oral Microbiology and Immunology

Volumn 18, Issue 6, 2003, Pages 405-407

  Kuriyama, T ^a   Williams, David W ^a   Lewis, M A O ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Candida albicans; Oral candidosis; Secreted aspartyl proteinase

Indexed keywords

ASPARTIC PROTEINASE;

ARTICLE; BURNING MOUTH SYNDROME; CANDIDA ALBICANS; ENZYME ACTIVITY; ENZYME RELEASE; FUNGUS ISOLATION; HUMAN; LICHEN PLANUS; NONHUMAN; SQUAMOUS CELL CARCINOMA; THRUSH; XEROSTOMIA;

ASPARTIC ENDOPEPTIDASES; BURNING MOUTH SYNDROME; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARCINOMA, SQUAMOUS CELL; CHRONIC DISEASE; ERYTHEMA; HUMANS; HYPERPLASIA; LICHEN PLANUS, ORAL; MOUTH DISEASES; MOUTH NEOPLASMS; PEPSTATINS; PROTEASE INHIBITORS; XEROSTOMIA;

EID: 0242390495     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-0055.2002.00100.x     Document Type: Article

References (13)

1. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis? J Dent Res 1995: 74: 1152-1161.
2. Cassone A, De Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis 1987: 156: 777-783.
3. De Bernardis F, Chiani P, Ciccozzi M, Pellegrini G, Ceddia T, D'Offizzi G, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 1996: 64: 466-471.
4. Hannula J, Saarela M, Dogan B, Paatsama J, Koukila-Kähkölä P, Pirinen S, et al. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol Immunol 2000: 15: 238-244.
5. Hoegl L, Ollert M, Korting HC. The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med 1996: 74: 135-142.
6. Hube B, Sanglard D, Odds FC, Hess D, Monod M, Schafer W, et al. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun 1997: 65: 3529-3538.
7. Gerson SJ. Oral cancer. Crit Rev Oral Biol Med 1990: 1: 153-166.
8. Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol 1987: 63: 48-54.
9. Kurnatowska AJ. Search for correlation between symptoms and signs of changes in the oral mucosa and presence of fungi. Mycoses 2001: 44: 379-382.
10. McMullan-Vogel CG, Jude HD, Ollert MW, Vogel CW. Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis. Oral Microbiol Immunol 1999: 14: 183-189.
11. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986: 15: 386-388.
12. Williams DW, Potts AJ, Wilson MJ, Matthews JB, Lewis MAO. Characterisation of the inflammatory cell infiltrate in chronic hyperplastic candidosis of the oral mucosa. J Oral Pathol Med 1997: 26: 83-89.
13. Wu T, Samaranayake LP, Cao BY, Wang J. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol 1996: 44: 311-316.